Adial Pharmaceuticals Statistics Share Statistics Adial Pharmaceuticals has 15.78M
shares outstanding. The number of shares has increased by 146.37%
in one year.
Shares Outstanding 15.78M Shares Change (YoY) 146.37% Shares Change (QoQ) 139.95% Owned by Institutions (%) 1.28% Shares Floating 14.93M Failed to Deliver (FTD) Shares 17,071 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 341.21K, so 2.16% of the outstanding
shares have been sold short.
Short Interest 341.21K Short % of Shares Out 2.16% Short % of Float 2.18% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.42 and the forward
PE ratio is -0.63.
Adial Pharmaceuticals's PEG ratio is
0.02.
PE Ratio -1.42 Forward PE -0.63 PS Ratio 0 Forward PS 0.1 PB Ratio 4.62 P/FCF Ratio -2.71 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Adial Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.16,
with a Debt / Equity ratio of 0.
Current Ratio 4.16 Quick Ratio 4.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.64M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -39% in the
last 52 weeks. The beta is 1.02, so Adial Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.02 52-Week Price Change -39% 50-Day Moving Average 0.48 200-Day Moving Average 0.78 Relative Strength Index (RSI) 66.23 Average Volume (20 Days) 9,176,881
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.28M Net Income -13.2M EBITDA -13.2M EBIT -13.2M Earnings Per Share (EPS) -0.71
Full Income Statement Balance Sheet The company has 3.75M in cash and 0 in
debt, giving a net cash position of 3.75M.
Cash & Cash Equivalents 3.75M Total Debt n/a Net Cash n/a Retained Earnings -82M Total Assets 3.45M Working Capital 1.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.92M
and capital expenditures 0, giving a free cash flow of -6.92M.
Operating Cash Flow -6.92M Capital Expenditures n/a Free Cash Flow -6.92M FCF Per Share -0.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ADIL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ADIL is $8,
which is 1211.5% higher than the current price. The consensus rating is "Buy".
Price Target $8 Price Target Difference 1211.5% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 7, 2023. It was a
backward
split with a ratio of 1:25.
Last Split Date Aug 7, 2023 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -39.6 Piotroski F-Score 1
